Envista Share Price (NYSE: NVST)

$21.73

▲

1.27

(6.21%)

Last updated on August 23, 2025 at 1:29 AM IST

$₹

Check the interactive Envista Stock chart to analyse performance

Envista stock performance

as on August 23, 2025 at 1:29 AM IST

Today's Low:$20.71
Today's High:$21.73
$21.73
4.69%
Downside
Day's Volatility :4.69%
Upside
0.0%
52 Weeks Low:$14.22
52 Weeks High:$23.00
$21.73
34.56%
Downside
52 Weeks Volatility :38.17%
Upside
5.52%

Envista Stock Returns

Period	Envista Holdings	Sector (Health Care)	Index (Russel 2000)
3 Months	20.69%	6.0%	0.0%
6 Months	1.57%	-5.6%	0.0%
1 Year	17.94%	-11.1%	0.0%
3 Years	-43.2%	6.8%	-7.8%

Envista Holdings Key Stats

Check Envista key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$20.46
Open	$20.71
Today's High	$21.73
Today's Low	$20.71
Market Capitalization	$3.4B
Today's Volume	$1.6M
52 Week High	$23.0
52 Week Low	$14.22
Revenue TTM	$2.6B
EBITDA	$309.9M
Earnings Per Share (EPS)	$0.32
PE Ratio	63.94
Profit Margin	2.11%
Quarterly Earnings Growth YOY	-0.27%
Return On Equity TTM	1.76%

Stock Returns calculator for Envista Stock including INR - Dollar returns

The Envista stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Envista investment value today

Current value as on today

₹1,22,285

Returns

₹22,285

(+22.29%)

Returns from Envista Stock

₹17,970 (+17.97%)

Dollar Returns*

₹4,316 (+4.32%)

Indian investors sentiment towards Envista Stock

157%

Period: Jul 24, 2025 to Aug 23, 2025. Change in 30 Days versus previous period

Search interest for Envista Stock from India on INDmoney has increased by 157% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Envista Holdings

Name
Holdings %
Name
Holdings %
BlackRock Inc
12.11%
Vanguard Group Inc
10.22%
Morgan Stanley - Brokerage Accounts
8.32%
Ariel Investments, LLC
7.31%
Dimensional Fund Advisors, Inc.
5.52%
Franklin Resources Inc
5.39%

Analyst Recommendation on Envista Stock

Rating

Trend

Buy

47%Buy

42%Hold

10%Sell

Based on 19 Wall street analysts offering stock ratings for Envista(by analysts ranked 0 to 5 stars)

Envista Share Price Target

What analysts predicted

Downside of 1.44%

Target:

$21.42

Current:

$21.73

Envista share price target is $21.42, a slight Downside of 1.44% compared to current price of $21.73 as per analysts' prediction.

Envista Stock Insights

Price Movement
In the last 3 months, NVST stock has moved up by 29.9%
Increasing Revenue
Revenue is up for the last 2 quarters, 616.9M → 682.1M (in $), with an average increase of 9.6% per quarter
Increasing Net Profit
Netprofit is up for the last 3 quarters, 1.2M → 26.4M (in $), with an average increase of 62.6% per quarter
NVST vs RMD (1 yr)
In the last 1 year, Resmed Inc. has given 29.6% return, outperforming this stock by 13.4%
NVST vs ISRG (3 yr)
In the last 3 years, Intuitive Surgical, Inc. has given 30.7% return, outperforming this stock by 71.6%
Price to Sales
ForNVST every $1 of sales, investors are willing to pay $1.5, whereas for Resmed Inc., the investors are paying $8.4 for every $1 of sales.

Envista Holdings Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$2.8B	↓ 3.27%
Net Income	$217.6M	↓ 5.68%
Net Profit Margin	7.91%	↓ 0.2%

	FY20	Y/Y Change
Revenue	$2.3B	↓ 17.07%
Net Income	$33.3M	↓ 84.7%
Net Profit Margin	1.46%	↓ 6.45%

	FY21	Y/Y Change
Revenue	$2.5B	↑ 9.94%
Net Income	$263.5M	↑ 691.29%
Net Profit Margin	10.5%	↑ 9.04%

	FY22	Y/Y Change
Revenue	$2.6B	↑ 2.4%
Net Income	$243.1M	↓ 7.74%
Net Profit Margin	9.46%	↓ 1.04%

	FY23	Y/Y Change
Revenue	$2.6B	↓ 0.1%
Net Income	$-100.2M	↓ 141.22%
Net Profit Margin	-3.9%	↓ 13.36%

	FY24	Y/Y Change
Revenue	$2.5B	↓ 2.18%
Net Income	$-1.1B	↑ 1016.37%
Net Profit Margin	-44.56%	↓ 40.66%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$623.6M	↓ 3.41%
Net Income	$23.6M	↓ 110.86%
Net Profit Margin	3.78%	↑ 37.45%

	Q2 FY24	Q/Q Change
Revenue	$633.1M	↑ 1.52%
Net Income	$-1.2B	↓ 4979.66%
Net Profit Margin	-181.9%	↓ 185.68%

	Q3 FY24	Q/Q Change
Revenue	$601.0M	↓ 5.07%
Net Income	$8.2M	↓ 100.71%
Net Profit Margin	1.36%	↑ 183.26%

	Q4 FY24	Q/Q Change
Revenue	$652.9M	↑ 8.64%
Net Income	$1.2M	↓ 85.37%
Net Profit Margin	0.18%	↓ 1.18%

	Q1 FY25	Q/Q Change
Revenue	$616.9M	↓ 5.51%
Net Income	$18.0M	↑ 1400.0%
Net Profit Margin	2.92%	↑ 2.74%

	Q2 FY25	Q/Q Change
Revenue	$682.1M	↑ 10.57%
Net Income	$26.4M	↑ 46.67%
Net Profit Margin	3.87%	↑ 0.95%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$1.5B	↓ 5.54%

	FY20	Y/Y Change
Profit	$1.2B	↓ 23.46%

	FY21	Y/Y Change
Profit	$1.4B	↑ 23.18%

	FY22	Y/Y Change
Profit	$1.5B	↑ 3.39%

	FY23	Y/Y Change
Profit	$1.4B	↓ 2.33%

	FY24	Y/Y Change
Profit	$1.4B	↓ 4.71%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$358.0M	↑ 6.58%

	Q2 FY24	Q/Q Change
Profit	$329.9M	↓ 7.85%

	Q3 FY24	Q/Q Change
Profit	$317.3M	↓ 3.82%

	Q4 FY24	Q/Q Change
Profit	$372.5M	↑ 17.4%

	Q1 FY25	Q/Q Change
Profit	$336.0M	↓ 9.8%

	Q2 FY25	Q/Q Change
Profit	$370.2M	↑ 10.18%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$397.5M	↓ 0.65%
Investing Cash Flow	$-78.4M	↑ 3.84%
Financing Cash Flow	$-107.7M	↓ 66.82%

	FY20	Y/Y Change
Operating Cash Flow	$283.9M	↓ 28.58%
Investing Cash Flow	$-69.1M	↓ 11.86%
Financing Cash Flow	$492.5M	↓ 557.29%

	FY21	Y/Y Change
Operating Cash Flow	$391.4M	↑ 37.87%
Investing Cash Flow	$232.9M	↓ 437.05%
Financing Cash Flow	$-465.6M	↓ 194.54%

	FY22	Y/Y Change
Operating Cash Flow	$182.7M	↓ 53.32%
Investing Cash Flow	$-657.3M	↓ 382.22%
Financing Cash Flow	$12.5M	↓ 102.68%

	FY23	Y/Y Change
Operating Cash Flow	$275.7M	↑ 50.9%
Investing Cash Flow	$-62.4M	↓ 90.51%
Financing Cash Flow	$118.9M	↑ 851.2%

	FY24	Y/Y Change
Operating Cash Flow	$336.5M	↑ 22.05%
Investing Cash Flow	$-54.6M	↓ 12.5%
Financing Cash Flow	$-103.7M	↓ 187.22%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$40.3M	↓ 60.49%
Investing Cash Flow	$-10.7M	↓ 15.08%
Financing Cash Flow	$-2.6M	↓ 178.79%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$93.1M	↑ 131.02%
Investing Cash Flow	$-5.9M	↓ 44.86%
Financing Cash Flow	$300.0K	↓ 111.54%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$70.7M	↓ 24.06%
Investing Cash Flow	$-30.6M	↑ 418.64%
Financing Cash Flow	$-100.5M	↓ 33600.0%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$132.4M	↑ 87.27%
Investing Cash Flow	$-7.4M	↓ 75.82%
Financing Cash Flow	$-900.0K	↓ 99.1%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$300.0K	↓ 99.77%
Investing Cash Flow	$-8.8M	↑ 18.92%
Financing Cash Flow	$-17.6M	↑ 1855.56%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$88.7M	↑ 29466.67%
Investing Cash Flow	$-17.1M	↑ 94.32%
Financing Cash Flow	$17.6M	↓ 200.0%

Envista Technicals Summary

Sell

Neutral

Buy

Envista is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Envista Holdings Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Envista Holdings	5.1%	1.57%	17.94%	-43.2%	-7.75%
Intuitive Surgical, Inc.	-3.98%	-19.44%	-0.64%	111.58%	104.19%
Alcon Ag	-10.69%	-8.13%	-13.82%	17.64%	38.32%
West Pharmaceutical Services Inc	-6.01%	12.04%	-18.39%	-21.29%	-9.8%
Resmed Inc.	6.72%	27.87%	30.02%	28.11%	63.97%
Becton, Dickinson And Company	7.78%	-13.27%	-15.46%	-23.18%	-21.91%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Envista Holdings	63.94	63.94	NA	1.11	0.02	0.02	NA	18.82
Intuitive Surgical, Inc.	65.35	65.35	3.52	8.12	0.16	0.09	NA	49.79
Alcon Ag	36.66	36.66	2.16	3.09	0.05	0.03	0.0	44.73
West Pharmaceutical Services Inc	36.38	36.38	3.56	6.76	0.18	0.11	0.0	40.74
Resmed Inc.	30.29	30.29	1.95	9.5	0.26	0.14	0.01	40.77
Becton, Dickinson And Company	35.88	35.88	1.0	14.37	0.06	0.04	0.02	88.87

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Envista Holdings	Buy	$3.4B	-7.75%	63.94	2.11%
Intuitive Surgical, Inc.	Buy	$168.4B	104.19%	65.35	28.51%
Alcon Ag	Buy	$39.3B	38.32%	36.66	10.7%
West Pharmaceutical Services Inc	Buy	$17.4B	-9.8%	36.38	16.48%
Resmed Inc.	Buy	$42.2B	63.97%	30.29	27.22%
Becton, Dickinson And Company	Buy	$56.4B	-21.91%	35.88	7.41%

About Envista Holdings

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products. This segment also provides software packages, which include DTX Studio Implant; DTX Studio Lab; and DTX Studio Clinic, a software package offered with its imaging products. It offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.

Organization	Envista
Employees	12300
CEO	Mr. Paul A. Keel
Industry	Health Technology

Key Management of Envista Holdings

Name	Title
Mr. Paul A. Keel	CEO & Director
Mr. Eric D. Hammes	Senior VP & CFO
Mr. Mark E. Nance J.D.	Senior VP, General Counsel & Secretary
Mr. Mischa M. Reis	Senior Vice President of Strategy & Corporate Development
Mr. Robert Befidi Jr.	President of Diagnostics
Mr. Faez Kaabi	VP, Chief Accounting Officer & Corporate Controller
Mr. Andrew Chen	Chief Information Officer
Mr. Jim Gustafson	Vice President of Investor Relations
Paul Sumilas	Chief Compliance Officer
Mr. Suraj Satpathy	Chief Human Resources officer

Important FAQs about investing in NVST Stock from India :

What is Envista share price today?

Envista share price today is $21.73 as on August 23, 2025 at 1:29 AM IST at the close of the market. Envista share today touched a day high of $21.73 and a low of $20.71.

What is the 52 week high and 52 week low for Envista share?

Envista share touched a 52 week high of $23.00 and a 52 week low of $14.22. Envista stock price today i.e. August 23, 2025 at 1:29 AM IST is closed at $21.73, lower by 5.52% versus the 52 week high.

How to invest in Envista Stock (NVST) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Envista on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Envista Shares that will get you 0.0690 shares as per Envista share price of $21.73 per share as on August 23, 2025 at 1:29 AM IST.

What is the minimum amount required to buy Envista Stock (NVST) from India?

Indian investors can start investing in Envista (NVST) shares with as little as ₹87.521 or $1 (as of August 24, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹875.21 in Envista stock (as per the Rupee-Dollar exchange rate as on August 24, 2025). Based on Envista share’s latest price of $21.73 as on August 23, 2025 at 1:29 AM IST, you will get 0.4602 shares of Envista. Learn more about fractional shares .

What are the returns that Envista has given to Indian investors in the last 5 years?

Envista stock has given -7.75% share price returns and 18.0% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?